Cargando…
High-throughput investigation of molecular and cellular biomarkers in NMOSD
OBJECTIVE: To identify candidate biomarkers associated with neuromyelitis optica spectrum disorder (NMOSD) using high-throughput technologies that broadly assay the concentrations of serum analytes and frequencies of immune cell subsets. METHODS: Sera, peripheral blood mononuclear cells (PBMCs), and...
Autores principales: | Yandamuri, Soumya S., Jiang, Ruoyi, Sharma, Aditi, Cotzomi, Elizabeth, Zografou, Chrysoula, Ma, Anthony K., Alvey, Jessica S., Cook, Lawrence J., Smith, Terry J., Yeaman, Michael R., O'Connor, Kevin C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7413712/ https://www.ncbi.nlm.nih.gov/pubmed/32753407 http://dx.doi.org/10.1212/NXI.0000000000000852 |
Ejemplares similares
-
Clinical and epidemiological correlates of treatment change in patients with NMOSD: insights from the CIRCLES cohort
por: Gholizadeh, Shervin, et al.
Publicado: (2022) -
Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD
por: Cook, Lawrence J., et al.
Publicado: (2019) -
Associations of IRAK1 Gene Polymorphisms and mRNA Expression With NMOSD Risk in the Northern Chinese Han Population
por: Yan, Hongjing, et al.
Publicado: (2021) -
Adverse Events in NMOSD Therapy
por: Giglhuber, Katrin, et al.
Publicado: (2022) -
Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD
por: Shi, Mingchao, et al.
Publicado: (2022)